| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/12/2012 | CN101760446B Method for preparing monocyte type stem cell and application |
| 09/12/2012 | CN101583598B Novel indole derivative having inhibitory activity on i kappa b kinase |
| 09/12/2012 | CN101524344B Compositions used for releasing the pain of skin |
| 09/11/2012 | US8263637 Methods for treatment of multiple myeloma using cyclopropane carboxylic acid {2-[(is)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1 h-isoindol-4-yl}-amide |
| 09/11/2012 | US8263614 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 09/11/2012 | US8263597 Indazole compounds as CCR1 receptor antagonists |
| 09/11/2012 | US8263567 A lipophilic anthracycline with a pharmaceutically acceptable carrier for topical administration to a body surface and which has a higher lipophilicity than doxorubicin; valrubicin applied to mucous membranes; psoriasis; side effect reduction; not doxorubicin, daunorubicin, epirubicin or idarubicin |
| 09/11/2012 | US8263565 Nanoemulsion comprising metabolites of ginseng saponin as an active component and a method for preparing the same, and a skin-care composition for anti-aging containing the same |
| 09/11/2012 | US8263121 Solid pharmaceutical preparation |
| 09/11/2012 | US8263118 Bioresorbable fillers constituted by phospholipid liposomes and hyaluronic acid and/or the derivatives thereof |
| 09/11/2012 | US8263114 mixture of silicone fluid , silica and drug; wound dressing; topical applying; drug delivery |
| 09/11/2012 | US8263070 Using immunoglobulin specific to receptor for OX-2 membrane glycoprotein as diagnostic and therapeutic tool for treatment and prevention of asthma, infection, allergies, skin and cell proliferative disorders |
| 09/11/2012 | US8263054 Method of enhancing hair growth |
| 09/11/2012 | US8262054 Furnace mount |
| 09/11/2012 | CA2526570C Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant |
| 09/11/2012 | CA2480881C Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same |
| 09/11/2012 | CA2474402C Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds |
| 09/07/2012 | WO2012119056A1 Proteasome inhibitor delanzomib for use in the treatment of lupus |
| 09/07/2012 | WO2012118191A1 Aqueous solution containing hyaluronic acid or salt thereof |
| 09/07/2012 | WO2012118154A1 Novel vitamin d receptor modulator with partial agonist activity |
| 09/07/2012 | WO2012118097A1 Cell sheet having hyaluronic acid production ability and method for producing same |
| 09/07/2012 | WO2012117340A1 Method for the cosmetic treatment of skin redness |
| 09/07/2012 | WO2012116391A1 Cosmetic or pharmaceutical formulation |
| 09/07/2012 | WO2012097052A3 Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseases |
| 09/07/2012 | WO2012067404A3 Composition for anti-aging containing artemisia annua l. as active ingredient |
| 09/07/2012 | CA2827653A1 Proteasome inhibitor delanzomib for use in the treatment of lupus |
| 09/06/2012 | US20120225937 Crystalline forms and processes for the preparation of pg12 receptor agonists |
| 09/06/2012 | US20120225936 Method for producing triptolide |
| 09/06/2012 | US20120225915 Compositions and Methods of Using R(+) Pramipexole |
| 09/06/2012 | US20120225914 Treatment of sunburn using analgesics and antihistamines |
| 09/06/2012 | US20120225904 New 7-Phenyl-[1,2,4]triazolo[4,3-a]Pyridin-3(2H)-One Derivatives |
| 09/06/2012 | US20120225898 Hair growth and/or regrowth compositions |
| 09/06/2012 | US20120225897 Hair growth and/or regrowth compositions |
| 09/06/2012 | US20120225889 Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders |
| 09/06/2012 | US20120225883 Compounds for inflammation and immune-related uses |
| 09/06/2012 | US20120225879 Substituted 5-imino-1,2,4-thiadiazoles that can be used to treat neurodegenerative diseases |
| 09/06/2012 | US20120225878 Compounds |
| 09/06/2012 | US20120225875 Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors |
| 09/06/2012 | US20120225872 Methods of preparing and using quinazoline and quinoline derivatives |
| 09/06/2012 | US20120225857 Mst1 kinase inhibitors and methods of their use |
| 09/06/2012 | US20120225855 Triazolopyridine jak inhibitor compounds and methods |
| 09/06/2012 | US20120225852 Use of steroid compounds |
| 09/06/2012 | US20120225847 Squaric acid derivatives as inhibitors of the nicotinamide |
| 09/06/2012 | US20120225842 Hyaluronic acid compositions for dermatological use |
| 09/06/2012 | US20120225815 Novel Cellular Factor-Containing Solution Compositions |
| 09/06/2012 | US20120225808 Pharmaceutical Composition for Preventing / Treating TRPV1 Activity-Related and Inflammation-Related Diseases or Conditions Containing Maillard Peptide Separated from Well-Aged Traditional Soy Sauce as Active Ingredient |
| 09/06/2012 | US20120225445 Sebocytes, sebocyte cell lines and applications thereof |
| 09/06/2012 | US20120225147 Topical skin care formulations |
| 09/06/2012 | US20120225132 Methods for Increasing the Kinetic Activity of Alcohol, Water and Other Liquids, so as to Render the Liquids More Capable of Enhancing the Alternative Cellular Energy Pathway in the Prevention and Therapy of Diseases |
| 09/06/2012 | US20120225108 Products for improving wound healing |
| 09/06/2012 | US20120225107 Stable skin and scar treatment composition |
| 09/06/2012 | US20120225105 Sugar-based dispersion |
| 09/06/2012 | US20120225102 Perfluorocarbon gel formulations |
| 09/06/2012 | US20120225088 Compositions and methods for treating cancer and other diseases |
| 09/06/2012 | US20120225080 Human antibodies that bind the p40 subunit of human il-12/il-23 and uses therefor |
| 09/06/2012 | US20120225057 Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases |
| 09/06/2012 | US20120225053 Compositions and methods for the prevention and treatment of conditions associated with inflamation |
| 09/06/2012 | US20120225052 Composition and method for treating tissue defects |
| 09/06/2012 | US20120225048 Novel Cellular Factor-Containing Solution Compositions |
| 09/06/2012 | US20120225032 Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo |
| 09/06/2012 | US20120225029 Skin Cream |
| 09/06/2012 | US20120225023 Peptide protection against ultraviolet light toxicity |
| 09/06/2012 | US20120225012 Composition for hard tissue repair |
| 09/05/2012 | EP2495250A2 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
| 09/05/2012 | EP2494989A1 Photodynamic therapy for the treatment of acne |
| 09/05/2012 | EP2494977A1 Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood |
| 09/05/2012 | EP2494973A1 Topical compositions for the treatment and prevention of skin diseases, in particular radiation dermatitis caused by ionising radiation |
| 09/05/2012 | EP2494968A1 Compound, in particular dermatological ointment with Olea Europaea Fruit Oil and Silver |
| 09/05/2012 | EP2494965A2 Vitamin K for Prevention and Treatment of Skin Rash Secondary to Anti-EGFR Therapy |
| 09/05/2012 | EP2493572A1 Angiogenesis promoted by caged growth factors |
| 09/05/2012 | EP2493483A2 Rosacea topical skin treatment method and formulation |
| 09/05/2012 | EP2493465A2 Treatment of sunburn using analgesics and antihistamines |
| 09/05/2012 | EP2493461A1 Therapeutic uses of oligomeric and polymeric monoterpenes |
| 09/05/2012 | EP2493309A1 Methods of treating or preventing acute erythema |
| 09/05/2012 | CN202409549U External burn patch |
| 09/05/2012 | CN1956994B Epithelial cell growth promoter |
| 09/05/2012 | CN1955170B Class I tanshinone II A derivative and its application in pharmacy |
| 09/05/2012 | CN102656134A Method for producing reduced coenzyme Q10, method for stabilizing same, and composition comprising same |
| 09/05/2012 | CN102656133A Method for producing reduced coenzyme Q10, method for stabilizing same, and composition comprising same |
| 09/05/2012 | CN102655881A Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder |
| 09/05/2012 | CN102655869A Vitamin D3 and analogs thereof for treating alopecia |
| 09/05/2012 | CN102653515A Polycationic compounds and uses thereof |
| 09/05/2012 | CN102652829A Extraction method of ginseng peptide |
| 09/05/2012 | CN102652823A Full traditional Chinese medicine preparation for preventing hair loss and growing hairs |
| 09/05/2012 | CN102652789A Traditional Chinese medicine for treating thrombocytopenic purpura |
| 09/05/2012 | CN102652775A Chinese herbal medicines for treating four idiopathic diseases |
| 09/05/2012 | CN102652773A Medicinal composition and preparation method thereof |
| 09/05/2012 | CN102652772A Chinese herbal medicine pill for treating psoriasis and neurodermatitis |
| 09/05/2012 | CN102652770A Jujube dead leaf wine |
| 09/05/2012 | CN102652765A Five-flavor poison drawing ointment |
| 09/05/2012 | CN102652763A Traditional Chinese medicine preparation for treating burn and scald and preparation method thereof |
| 09/05/2012 | CN102652754A Treatment of sweating |
| 09/05/2012 | CN102652730A Ointment base, kuh-seng and green tea ointment and preparation method of ointment |
| 09/05/2012 | CN102652728A Preparation method of hair-loss preventing shampoo |
| 09/05/2012 | CN102652726A Formula of traditional Chinese medicine whitening paste and manufacturing method |
| 09/05/2012 | CN102652725A Fruit peel extract and production device thereof |
| 09/05/2012 | CN102652719A Preparation method and application of biological skin care solution |
| 09/05/2012 | CN102266406B Chinese medicinal ointment for treating burn and preparation method |
| 09/05/2012 | CN102258663B Freckle removing capsules |
| 09/05/2012 | CN102205080B External application medicinal composition for treating leukoplakia vulvae |